Veterinary Medicines

Norfenicol 300 mg/ml Solution for Injection for Cattle and Pigs

Authorised
  • Florfenicol
Download as PDF

Product identification

Medicine name:
Norfenicol 300 mg/ml Solution for Injection for Cattle and Pigs
Norfenicol 300 mg/ml injektionsvæske, opløsning
Active substance:
  • Florfenicol
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Florfenicol
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        39
        day
    • Pig
      • Meat and offal
        22
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        44
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01BA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • 500 ml clear type I glass vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box or a protective sleeve.
  • 250 ml clear type I glass vial with bromobutyl rubber bung and aluminium presented in a cardboard box or a protective sleeve.
  • 100 ml clear type I glass vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box or a protective sleeve.
  • 50 ml clear type I glass vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box.
  • 50 ml HDPE plastic vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box.
  • 100 ml HDPE plastic vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box or a protective sleeve.
  • 250 ml HDPE plastic vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box or a protective sleeve.
  • 500 ml HDPE plastic vial with bromobutyl rubber bung and aluminium seal presented in a cardboard box or a protective sleeve.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 48668
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0282/001
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 26/09/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."